Alterations in Sphingolipid Composition and Mitochondrial Bioenergetics Represent Synergistic Therapeutic Vulnerabilities Linked to Multidrug Resistance in Leukemia
Author
Fisher-Wellman, Kelsey H.; Hagen, James T.; Nelson, Margaret A. M.; McLaughlin, Kelsey L.; Coalson, Hannah S.; Kassai, Miki; Kao, Li-Pin; Cabot, Myles C.
Date
2022-01
Citation:
APA:
Fisher-Wellman, Kelsey H., & Hagen, James T., & Nelson, Margaret A. M., & McLaughlin, Kelsey L., & Coalson, Hannah S., & Kassai, Miki, & Kao, Li-Pin, & Cabot, Myles C.. (January 2022).
Alterations in Sphingolipid Composition and Mitochondrial Bioenergetics Represent Synergistic Therapeutic Vulnerabilities Linked to Multidrug Resistance in Leukemia.
,
(),
-
. Retrieved from
http://hdl.handle.net/10342/11776
MLA:
Fisher-Wellman, Kelsey H., and Hagen, James T., and Nelson, Margaret A. M., and McLaughlin, Kelsey L., and Coalson, Hannah S., and Kassai, Miki, and Kao, Li-Pin, and Cabot, Myles C..
"Alterations in Sphingolipid Composition and Mitochondrial Bioenergetics Represent Synergistic Therapeutic Vulnerabilities Linked to Multidrug Resistance in Leukemia". .
. (),
January 2022.
April 25, 2024.
http://hdl.handle.net/10342/11776.
Chicago:
Fisher-Wellman, Kelsey H. and Hagen, James T. and Nelson, Margaret A. M. and McLaughlin, Kelsey L. and Coalson, Hannah S. and Kassai, Miki and Kao, Li-Pin and Cabot, Myles C.,
"Alterations in Sphingolipid Composition and Mitochondrial Bioenergetics Represent Synergistic Therapeutic Vulnerabilities Linked to Multidrug Resistance in Leukemia," , no.
(January 2022),
http://hdl.handle.net/10342/11776 (accessed
April 25, 2024).
AMA:
Fisher-Wellman, Kelsey H., Hagen, James T., Nelson, Margaret A. M., McLaughlin, Kelsey L., Coalson, Hannah S., Kassai, Miki, Kao, Li-Pin, Cabot, Myles C..
Alterations in Sphingolipid Composition and Mitochondrial Bioenergetics Represent Synergistic Therapeutic Vulnerabilities Linked to Multidrug Resistance in Leukemia. .
January 2022;
():
.
http://hdl.handle.net/10342/11776. Accessed
April 25, 2024.
Collections